- Home
- UCTT vs ORIC Comparison
UCTT vs ORIC Comparison
Compare UCTT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCTT
- ORIC
- Stock Information
- Founded
- UCTT 1991
- ORIC 2014
- Country
- UCTT United States
- ORIC United States
- Employees
- UCTT N/A
- ORIC N/A
- Industry
- UCTT Semiconductors
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- UCTT Technology
- ORIC Health Care
- Exchange
- UCTT Nasdaq
- ORIC Nasdaq
- Market Cap
- UCTT 1.0B
- ORIC 974.1M
- IPO Year
- UCTT 2004
- ORIC 2020
- Fundamental
- Price
- UCTT $24.38
- ORIC $10.88
- Analyst Decision
- UCTT Strong Buy
- ORIC Strong Buy
- Analyst Count
- UCTT 3
- ORIC 10
- Target Price
- UCTT $39.00
- ORIC $17.33
- AVG Volume (30 Days)
- UCTT 338.6K
- ORIC 782.2K
- Earning Date
- UCTT 10-27-2025
- ORIC 08-12-2025
- Dividend Yield
- UCTT N/A
- ORIC N/A
- EPS Growth
- UCTT N/A
- ORIC N/A
- EPS
- UCTT N/A
- ORIC N/A
- Revenue
- UCTT $2,141,100,000.00
- ORIC N/A
- Revenue This Year
- UCTT N/A
- ORIC N/A
- Revenue Next Year
- UCTT $4.45
- ORIC N/A
- P/E Ratio
- UCTT N/A
- ORIC N/A
- Revenue Growth
- UCTT 14.28
- ORIC N/A
- 52 Week Low
- UCTT $16.66
- ORIC $3.90
- 52 Week High
- UCTT $41.90
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- UCTT 55.64
- ORIC 63.04
- Support Level
- UCTT $22.74
- ORIC $9.87
- Resistance Level
- UCTT $24.92
- ORIC $10.35
- Average True Range (ATR)
- UCTT 0.82
- ORIC 0.44
- MACD
- UCTT 0.09
- ORIC 0.14
- Stochastic Oscillator
- UCTT 82.00
- ORIC 79.99
About UCTT Ultra Clean Holdings Inc.
Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.